Loading...
New Drug Repositioning Candidates for T-ALL Identified Via Human/Murine Gene Signature Comparison
T-cell Acute Lymphoblastic Leukemia (T-ALL) is an aggressive subtype of leukemia for which important progress in treatment efficiency have been made in the past decades to reach a cure rate of 75%–80% nowadays. It is nevertheless mandatory to find new targets and active molecules for innovative ther...
Na minha lista:
| Udgivet i: | Front Oncol |
|---|---|
| Main Authors: | , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Frontiers Media S.A.
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7680901/ https://ncbi.nlm.nih.gov/pubmed/33240808 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2020.557643 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|